With Alimera spending money faster than crackheads, it won't be too far fetched to see Medidur
(which is a lower dose of Fa; 1.8 micrograms with 27 gauge needle) be approved for DME should Alimera's demise continue. Wow, Alimera sure is disappointing investors.
Honest assessment Hernando. I'm looking forward to some color on the CC. The J code should kick in and at least help sales going into mid year. I've always wondered why they didn't get a J code in late 14' for US sales starting in 15'.
I'll wait for your color commentary. That will be far better. The Alimera MB has gotten run over by the bus long before we did. The rotting carcasses have long been forgotten. Lets hope they sold to a big pharma! That would bold well for all PSDV longs.
JD, That's a pretty good idea. It would be helpful to all investors. I think however, that it would be like pSivida and their web page ticker symbol that used to be on the front page of their home page. Wonder why they took it off? Embarrassing?